ULK2 and central nervous system cancer: Furthermore, our study revealed a significant downregulation of ULK2 expression in high-grade gliomas compared to low-grade ones, consistent with findings by Shulka et al. This downregulation of ULK2 in glioblastoma aligns with reported promoter hypermethylation and ULK2 downregulation in normal brain tissue.